Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Antihistamine + Leukotriene Antagonist + Mucolytic-Bronchodilator
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Allergic rhinitis with concurrent mild-to-moderate asthma
- Persistent allergic asthma with rhinitis (united airway disease)
- Cough-variant asthma with allergic component
- Post-viral airway hyperreactivity with allergic background
Mechanism of Action
Bilastine selectively blocks H1 receptors, suppressing histamine-driven rhinitis and itch. Montelukast antagonises CysLT1 leukotriene receptors on airway smooth muscle and inflammatory cells, reducing bronchoconstriction and eosinophilic inflammation. Acebrophylline is a xanthine derivative + ambroxol salt — providing mucolytic, surfactant-stimulating and mild PDE-inhibitor bronchodilator action.
Dosage & Administration
- Adults: 1 tablet once daily in the evening, swallowed whole.
- Re-evaluate response after 4 weeks.
- Step down to monotherapy when symptoms stabilise.
Side Effects
- Headache, mild GI upset, somnolence (low), behavioural changes (Montelukast — black-box warning for neuropsychiatric effects;
- counsel patient and monitor).
- Acebrophylline class: occasional GI upset, palpitations, tremor.
Contraindications
- Hypersensitivity to any component.
- Severe hepatic impairment.
- Concomitant fruit juices (reduce Bilastine absorption).
- History of suicidal ideation (Montelukast caution).
- Acute severe asthma exacerbation — not for rescue therapy.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet?
MRPs range from ₹2750 to ₹2750 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg (SR) Tablet?